BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7915591)

  • 1. A new approach of acute lymphoblastic leukemia immunophenotypic classification: 1984-1994 the GEIL experience. Groupe d'Etude Immunologique des Leucémies.
    Garand R; Béné MC
    Leuk Lymphoma; 1994; 13 Suppl 1():1-5. PubMed ID: 7915591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD2 + CD19 + acute lymphoblastic leukaemia in 16 children and adults: clinical and biological features. Groupe d'Etude Immunologique des Leucémies (G.E.I.L.).
    Lenormand B; Vannier JP; Bene MC; Falkenrodt A; Bayle C; Favre M; Garand R; Griveau AM; Briquet MT; Reman O
    Br J Haematol; 1993 Apr; 83(4):580-8. PubMed ID: 7686033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des Leucémies.
    Lenormand B; Béné MC; Lesesve JF; Bastard C; Tilly H; Lefranc MP; Faure GC; Garand R; Falkenrodt A; Kandel G; Solary E; Maynadié M; Callat MP; Thouret F; Monconduit M; Vannier JP
    Leuk Lymphoma; 1998 Jan; 28(3-4):329-42. PubMed ID: 9517504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutual benefits of B-ALL and HLDA/HCDM HLDA 9th Barcelona 2010.
    Faure GC; Amsellem S; Arnoulet C; Bardet V; Campos L; De Carvalho-Bittencourt M; de Labarthe A; Eischen A; Feuillard J; Fossat C; Ottou FG; Guérin E; Guy J; Jouault H; Kuhlein E; Lacombe F; Lainey E; Maynadié M; Noguera ME; Roussel M; Solly F; Ballon OW; Béné MC;
    Immunol Lett; 2011 Jan; 134(2):145-9. PubMed ID: 20951742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
    Solary E; Casasnovas RO; Campos L; Béné MC; Faure G; Maingon P; Falkenrodt A; Lenormand B; Genetet N
    Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized multicentric quantimetry of differentiation antigens expression. The GEIL's approach in acute lymphoblastic leukemia. Groupe d'Etude Immunologique des Leucémies.
    Philip P; Sartiaux C
    Leuk Lymphoma; 1994; 13 Suppl 1():45-8. PubMed ID: 8075579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panel proposal for the immunophenotypic diagnosis of hematological malignancies. A collaborative consensus from the groupe d'Etude Immunologique des Leucémies (GEIL).
    Collective Publication
    Cytometry B Clin Cytom; 2018 May; 94(3):542-547. PubMed ID: 29160946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
    Wiersma SR; Ortega J; Sobel E; Weinberg KI
    N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic analysis of a thousand cases of acute leukemia. French Groupe d'Etude Immunologique des Leucémies (GEIL).
    Béné MC; Boumsell L; Vannier JP; Garand R; Solary E; Faure G; Bernard A
    Nouv Rev Fr Hematol (1978); 1989; 31(2):133-6. PubMed ID: 2671926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucémies.
    Garand R; Voisin S; Papin S; Praloran V; Lenormand B; Favre M; Philip P; Bernier M; Vanhaecke D; Falkenrodt A
    Leukemia; 1993 Feb; 7(2):161-7. PubMed ID: 8426469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G; Coustan-Smith E; Campana D
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid lineage involvement in acute lymphoblastic leukemia: a morphology antibody chromosomes (MAC) study.
    Larramendy M; el-Rifai W; Saarinen U; Alitalo R; Luomahaara S; Knuutila S
    Exp Hematol; 1995 Dec; 23(14):1563-7. PubMed ID: 8542947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD10 in acute leukemias. GEIL (Groupe d'Etude Immunologique des Leucémies).
    Béné MC; Faure GC
    Haematologica; 1997; 82(2):205-10. PubMed ID: 9175328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases.
    Khalidi HS; Chang KL; Medeiros LJ; Brynes RK; Slovak ML; Murata-Collins JL; Arber DA
    Am J Clin Pathol; 1999 Apr; 111(4):467-76. PubMed ID: 10191766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of outcome, clinical, laboratory, and immunological features in 164 children and adults with T-ALL. The Groupe d'Etude Immunologique des Leucémies.
    Garand R; Vannier JP; Béné MC; Faure G; Favre M; Bernard A
    Leukemia; 1990 Nov; 4(11):739-44. PubMed ID: 2232884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
    Hurwitz CA; Gore SD; Stone KD; Civin CI
    Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients.
    Maecker B; Mougiakakos D; Zimmermann M; Behrens M; Hollander S; Schrauder A; Schrappe M; Welte K; Klein C
    Leukemia; 2006 Apr; 20(4):645-9. PubMed ID: 16498391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic classification used in typing of 68 cases of acute leukemias].
    Sun XL; Fang MY; Jiang F; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):39-41. PubMed ID: 16584588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the CD10 (cALLA) negative acute lymphoblastic leukaemia: further description of a group with a poor prognosis. French Groupe d'Etude Immunologique des Leucémies.
    Vannier JP; Bene MC; Faure GC; Bastard C; Garand R; Bernard A
    Br J Haematol; 1989 Jun; 72(2):156-60. PubMed ID: 2757961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
    Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
    Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.